Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer
Both
Cancer
Trial Information
Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Inclusion Criteria:
- Patients with a diagnosis of malignancy
Exclusion Criteria:
- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Chris E Holmes, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Vermont
Authority:
United States: Institutional Review Board
Study ID:
VCC 0806
NCT ID:
NCT01148407
Start Date:
June 2010
Completion Date:
August 2013
Related Keywords:
- Cancer
- breast cancer
- platelets
- metastatic cancer
- malignancy
Name | Location |
|---|---|
| University of Vermont/Fletcher Allen Health Care | Burlington, Vermont 05405 |
